Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Urol. 2020 Dec 24;205(5):1344–1351. doi: 10.1097/JU.0000000000001559

Figure 2:

Figure 2:

Boxplot of genomic risk scores by template and MRI guided biopsies for each tissue-based genomic prognostic signatures (Decipher, CCP, GPS) showing higher CCP scores in MRI targeted compared to template biopsies, but no difference in GPS and Decipher scores. Within MRI targeted biospies all signatures showed higher scores with higher PIRADS levels.

Red circles depict biopsies from MAST trial; Blue dots – from BlastM.